Anand Rathi Research has upgraded Narayana Hrudayalaya to a BUY rating with a revised target price of Rs 1,550, offering a potential upside of approximately 30% from its current price of Rs 1,196.
ICICI Direct has recommended a BUY rating on Narayana Hrudayalaya (NARHRU), a leading chain of multi-specialty hospitals, with a target price of Rs 1,485, representing a potential upside of 22% fro
Chola Securities has issued a BUY recommendation for Narayana Hrudayalaya Limited (NHL), a leading healthcare provider, known for its expertise in cardiac, oncology, and nephrology treatments.
